Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The dual GIP/GLP-1 receptor agonist tirzepatide represents a novel therapeutic approach, simultaneously activating both incretin pathways
Supplement-based approaches are positioned around supporting natural GLP-1 production through a fundamentally different mechanism and regulatory framework
: ,
Cysteine is also an amino acid constituent of glutathione, and glutamate production may support glutathione metabolism by increasing the intracellular availability of cysteine
If youre already using an injectable GLP-1 treatment and its working well for you, its likely you would be advised to continue with your current treatment
Transparent documentation and consistent quality control
